ストックスクリーナーアプリを入手
127.87
0.13%
-0.12
前日終値:
$127.75
開ける：
$127.5
24時間の取引高:
133.00K
Relative Volume:
0.09
時価総額：
$18.75B
収益：
$9.82B
当期純損益:
$1.48B
株価収益率:
12.62
EPS:
10.13
ネットキャッシュフロー:
$2.30B
1週間 パフォーマンス:
-3.31%
1か月 パフォーマンス:
-5.11%
6か月 パフォーマンス:
-9.74%
1年 パフォーマンス:
-37.48%
1日の値動き範囲:
$127.00
$128.78
1週間の範囲:
$127.00
$134.16
52週間の値動き範囲:
$110.03
$207.59
Biogen Inc Stock (BIIB) Company Profile
BIIB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
127.91 | 18.96B | 9.82B | 1.48B | 2.30B | 10.13 |
|
LLY
Lilly Eli Co
|
625.87 | 670.04B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
172.75 | 410.84B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
197.45 | 346.78B | 58.33B | 3.76B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
116.37 | 219.72B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
80.61 | 198.42B | 63.62B | 16.41B | 14.72B | 6.49 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 再開されました | Truist | Hold |
| 2025-04-28 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-04 | ダウングレード | Argus | Buy → Hold |
| 2025-02-11 | 開始されました | Bernstein | Mkt Perform |
| 2025-01-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-09 | ダウングレード | Jefferies | Buy → Hold |
| 2024-11-18 | ダウングレード | Needham | Buy → Hold |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-31 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-14 | 繰り返されました | Needham | Buy |
| 2024-02-14 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | ダウングレード | UBS | Buy → Neutral |
| 2023-12-20 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-12-07 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-07-24 | 繰り返されました | UBS | Buy |
| 2023-05-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-04-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | アップグレード | Goldman | Neutral → Buy |
| 2022-10-13 | アップグレード | Stifel | Hold → Buy |
| 2022-10-07 | アップグレード | Argus | Hold → Buy |
| 2022-09-28 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | アップグレード | Mizuho | Neutral → Buy |
| 2022-09-28 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | ダウングレード | Stifel | Buy → Hold |
| 2022-03-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-04 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-04 | 繰り返されました | Cowen | Outperform |
| 2022-02-04 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-04 | 繰り返されました | Needham | Buy |
| 2022-02-04 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | 繰り返されました | Robert W. Baird | Neutral |
| 2022-02-04 | 繰り返されました | Wedbush | Neutral |
| 2022-02-04 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-02-04 | 繰り返されました | Wolfe Research | Peer Perform |
| 2022-01-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-01-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-06-18 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | 繰り返されました | Truist | Buy |
| 2021-06-11 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | アップグレード | UBS | Neutral → Buy |
| 2021-06-08 | アップグレード | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | 繰り返されました | Barclays | Equal Weight |
| 2021-06-08 | アップグレード | Citigroup | Sell → Neutral |
| 2021-06-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-06-08 | 繰り返されました | Jefferies | Buy |
| 2021-06-08 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-06-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | 繰り返されました | Stifel | Buy |
| 2021-06-08 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-06-07 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-06-07 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | ダウングレード | DZ Bank | Buy → Hold |
| 2021-01-29 | アップグレード | Stifel | Hold → Buy |
| 2020-11-10 | アップグレード | DZ Bank | Hold → Buy |
| 2020-11-09 | ダウングレード | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-11-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-11-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-11-04 | アップグレード | Jefferies | Hold → Buy |
| 2020-11-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-07-27 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2020-06-22 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-04-23 | ダウングレード | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-27 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | ダウングレード | Robert W. Baird | Neutral → Underperform |
すべてを表示
Biogen Inc (BIIB) 最新ニュース
FDA Action Alert: Biogen/Eisai, Sanofi, Ionis and More - BioSpace
Headlands Technologies LLC Sells 3,608 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
iA Global Asset Management Inc. Acquires 2,636 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Arkadios Wealth Advisors Purchases Shares of 3,354 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Position Cut by J. Safra Sarasin Holding AG - MarketBeat
Eli Lilly And Biogen (And Eisai): Muddying The Waters In Alzheimer's Disease - Seeking Alpha
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment? - TipRanks
We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Primecap Management Co. CA Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Bank of Nova Scotia Sells 4,241 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Natixis Advisors LLC Acquires 9,946 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
What is William Blair's Forecast for Biogen Q2 Earnings? - MarketBeat
Global Renal Transplant Therapeutics Market is Expected to Cross ~USD 18 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates - MSN
Japan OKs Price Cut for Alzheimer's Drug Lecanemab - JIJI PRESS
US Bancorp DE Has $3.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Cantor Fitzgerald Brokers Lift Earnings Estimates for Biogen - MarketBeat
Biogen (NASDAQ:BIIB) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Raised to $135.00 at Citigroup - MarketBeat
Biogen (BIIB) Price Target Hiked to $130 at UBS amid Leqembi Development - MSN
Spinal Muscular Atrophy Market Opportunities and Future Scope - openPR.com
Fund Update: STATE OF MICHIGAN RETIREMENT SYSTEM added 251,600 shares of BIOGEN ($BIIB) to their portfolio - Quiver Quantitative
LSV Asset Management Grows Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Y Intercept Hong Kong Ltd Sells 13,310 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
HC Wainwright Issues Positive Forecast for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
Spinal Muscular Atrophy Pipeline Outlook 2025: Clinical trials, EMA, PDMA, FDA Approvals, Medication, Treatment Market, NDA Approval, Therapies, ROA, MOA and Companies by DelveInsight - Barchart.com
Biogen Inc. (BIIB): A Bull Case Theory - Insider Monkey
Biogen moving ‘rapidly’ in quest to bring salanersen to SMA patients - SMA News Today
BofA Lowers PT on Biogen (BIIB) to $142 From $143, Keeps a Neutral Rating - Insider Monkey
Chronic Lymphocytic Leukemia Therapeutics Market is Fueled - openPR.com
Banco Santander S.A. Purchases 7,182 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen is building a ‘ventures’ team to ‘keep early portfolio externalized’ - Endpoints News
Reversal Confirmed Biogen Inc. Stock Rallies Above MAReal-Time Trade Insights Spark Market Reactions - beatles.ru
Biogen (NASDAQ:BIIB) Updates FY 2025 Earnings Guidance - MarketBeat
Nicolet Advisory Services LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen's Earnings Beat and Leqembi Progress Might Change The Case For Investing In BIIB - simplywall.st
Biogen Stock (BIIB): Strong Q2 Performance Fuels Growth - Value The Markets
RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT - MSN
Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat
Leerink Partnrs Estimates Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat
Tredje AP fonden Purchases New Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Banque Cantonale Vaudoise Invests $1.35 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
XTX Topco Ltd Buys 14,459 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
When is Biogen Inc. stock expected to show significant growthAchieve breakthrough profits with smart strategies - Jammu Links News
What drives Biogen Inc. stock priceAchieve rapid portfolio appreciation - jammulinksnews.com
11 Cheap Pharmaceutical Stocks to Buy Now - Insider Monkey
How does Biogen Inc. compare to its industry peersGet daily expert analysis for smarter investing - Jammu Links News
Biogen (NASDAQ:BIIB) Releases Earnings Results, Beats Expectations By $1.54 EPS - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Boosted by R Squared Ltd - MarketBeat
Jefferies Financial Group Inc. Has $6.84 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc (BIIB) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.76%
大文字化:
|
ボリューム (24 時間):